CD8A and ovarian carcinoma: These analyses confirmed that low-risk ovarian cancer patients were positively associated with immune-relevant signatures (antigen-processing machinery, immune checkpoint, and CD8+ T effector) (Figure 5A and Supplementary Figure 3A).